Filtered By:
Source: Neurological Research
Condition: Ischemic Stroke
Countries: China Health

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 44 results found since Jan 2013.

Risk factors associated with recurrence of ischemic stroke after intracranial stenting in china: a case-control study
Conclusions: Recurrence of ischemic stroke after intracranial stenting may be associated with elderly age, non-smoking, and Mori C type lesion. These factors will need to be monitored in future trials of intracranial stenting.Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01968122.PMID:34148505 | DOI:10.1080/01616412.2021.1937877
Source: Neurological Research - June 21, 2021 Category: Neurology Authors: Guangwen Li Tonghui Liu Xiaoqing Ma Wentao Gong Xianjun Zhang Hongxia Wang Yunliang Guo Yuchuan Ding Yong Zhang Source Type: research

Predictors, timing, causes and cost of 30-day readmission after acute ischemic stroke: insights from a Chinese cohort 2015-2018
CONCLUSIONS: The findings highlight the importance of the readmission of ischemic stroke and corresponding policies and interventions, and our work could provide a potential manage path for the reduction of readmission rate.PMID:35876140 | DOI:10.1080/01616412.2022.2105489
Source: Neurological Research - July 25, 2022 Category: Neurology Authors: Chuang Liu Li Luo Qingqing Liu Qiaoqiao Ying Feifei Luo Jie Xiang Source Type: research

Effects of neuroserpin on clinical outcomes and inflammatory markers in Chinese patients with acute ischemic stroke.
CONCLUSIONS: A larger decrease in NSP levels related to lower levels of inflammatory marker, while higher NSP levels were associated with lower inflammatory markers and better functional outcomes. Decreasing the infarct size may play a role in this process. These results provide more evidence of the neuroprotective effect of NSP in cerebral ischemic patients. Decrease in the Serum NSP level and NSP level at admission may be considered as potential predictive factors for outcome of acute ischemic stroke. PMID: 28738762 [PubMed - as supplied by publisher]
Source: Neurological Research - July 26, 2017 Category: Neurology Tags: Neurol Res Source Type: research

Association of circulating blood HMGB1 levels with ischemic stroke: a systematic review and meta-analysis.
CONCLUSIONS: This meta-analysis demonstrates that circulating blood HMGB1 levels elevate in IS and higher HMGB1 levels may indicate a more serious condition. PMID: 30015578 [PubMed - as supplied by publisher]
Source: Neurological Research - July 19, 2018 Category: Neurology Tags: Neurol Res Source Type: research

The relationship between the platelet to leukocyte ratio and mechanical thrombectomy outcomes in acute ischemic stroke patients.
CONCLUSION: Platelet to leukocyte ratio may be use to assess the risk of functional outcome and sICH in patients with acute anterior circulation occlusion stroke undergoing endovascular treatment in real world China. PMID: 32643590 [PubMed - as supplied by publisher]
Source: Neurological Research - July 11, 2020 Category: Neurology Tags: Neurol Res Source Type: research

C-Reaction Protein and the Severity of Intracerebral Hemorrhage: A Study from Chinese Stroke Center Alliance
CONCLUSIONS: High CRP level was independently associated with poorer clinical outcome and higher in-hospital death in patients with ICH.PMID:34559025 | DOI:10.1080/01616412.2021.1980842
Source: Neurological Research - September 24, 2021 Category: Neurology Authors: Dandan Wang Jing Wang Zixiao Li Hongqiu Gu Kaixuan Yang Xingquan Zhao Yongjun Wang Source Type: research

Low-dose rt-PA may not decrease the incidence of symptomatic intracranial haemorrhage in patients with high risk of symptomatic intracranial haemorrhage.
CONCLUSIONS: Our study suggests that low-dose intravenous rt-PA for high-risk sICH stroke in Chinese patients may not decrease the incidence of sICH, and concomitant with a poor outcome compared to standard-dose rt-PA. ABBREVIATIONS: rt-PA: recombinant tissue plasminogen activator; AIS: acute ischemic stroke; sICH: symptomatic intracranial haemorrhage. PMID: 30822264 [PubMed - as supplied by publisher]
Source: Neurological Research - March 5, 2019 Category: Neurology Tags: Neurol Res Source Type: research